RNA Interference-based Therapies for the Reduction of Cardiovascular Risk
Nazarenko N, Seo J, Nagraj S, Palaiodimos L, Kokkinidis D. RNA Interference-based Therapies for the Reduction of Cardiovascular Risk. Current Molecular Pharmacology 2024, 17: e18761429264553. PMID: 38449067, DOI: 10.2174/0118761429264553231204115314.Peer-Reviewed Original ResearchLDL-C levelsLDL-CReduction of cardiovascular riskRNA interference-based therapiesSignificant cardiovascular eventsLDL-C level reductionRisk of cardiovascular diseaseCases of coronary artery diseaseNon-modifiable risk factorsCoronary artery diseasePrevalent risk factorIncidence of CVDLowering lipid levelsRisk factors of heart diseaseCardiovascular eventsFactors of heart diseaseMortality benefitCardiovascular riskArtery diseaseRisk factorsHeart diseaseLipid levelsCardiovascular diseasePrevent 2Lifestyle factors